Status:
COMPLETED
Rollover Study of Weekly Paclitaxel (BMS-181339) in Patients With Head and Neck Cancer
Lead Sponsor:
Bristol-Myers Squibb
Conditions:
Head and Neck Cancer
Eligibility:
All Genders
Phase:
PHASE2
Brief Summary
The purpose of this study is to provide access to paclitaxel therapy to subjects with advanced head and neck cancer who have completed the previous late phase 2 study (CA139-388) and should have conti...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Subjects with advanced head and neck cancer who have completed the previous late phase 2 study (CA139-388) and should have continued therapy with paclitaxel as the discretion of the investigator
Exclusion
Key Trial Info
Start Date :
August 4 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 26 2008
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT00971867
Start Date
August 4 2006
End Date
November 26 2008
Last Update
April 8 2022
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
Local Institution
Kashiwa-shi, Chiba, Japan, 2778577
2
Local Institution
Matsuyama, Ehime, Japan
3
Local Institution
Kagoshima, Kagoshima-ken, Japan, 8900075
4
Local Institution
Yokohama, Kanagawa, Japan, 241-0815